Reuters -- Nycomed, the private equity-owned Swiss drugmaker, recently made a fully financed 4 to 4.5 billion-euro ($5.88 to $6.62 billion) offer to buy Solvay SA's drug unit, people familiar with the matter said.
Reuters -- Nycomed, the private equity-owned Swiss drugmaker, recently made a fully financed 4 to 4.5 billion-euro ($5.88 to $6.62 billion) offer to buy Solvay SA's drug unit, people familiar with the matter said.
